Biotech firm brings in IDS Scheer for U.S. deployment of pharma solution in first phase of global project
Berwyn, PA — November 10, 2003 — Biotech firm Celltech Group has tapped consultancy IDS Scheer to improve the company's business processes and help deploy the mySAP Business Suite software, including SAP Best Practices for Pharmaceuticals.
Celltech is a leading European biotechnology company, with extensive pharmaceutical operations in the United States and Europe.
IDS said it will provide Celltech with business process consulting services to help maximize the business value of the mySAP Business Suite software implementation. The consultancy is helping Celltech leverage the capabilities of the SAP Best Practices for Pharmaceuticals that will form the backbone of the SAP solution implementation.
The first phase, scheduled to go live in January 2005, will replace Celltech North America's disparate legacy systems with an implementation that will support multiple business processes — including sales, inventory and contract management — on a single platform. Pending the results of phase one, Celltech plans a global rollout across the entire organization.
According to David Mayor, project leader on the Celltech SAP implementation team, the decision to engage IDS Scheer was based on the solutions approach presented. "We found that IDS Scheer consultants took the time to understand our needs and presented a comprehensive solution versus a boxed product," he said.
Richard Simon, IT systems architect who is working with Mayor on managing the technical infrastructure aspects of the SAP solution implementation at Celltech, cited the scalability of the SAP platform as a key plus for the solution. "It was critical for us to buy into an expandable platform to scale with us today and deploy more cost-effectively in the future," Simon said.
Simon wants to optimize the SAP solution landscape with clustering and redundancy for high availability and multi-site presence for disaster recovery so that SAP can become the cornerstone business enabling platform for future initiatives within Celltech. "Our eventual goal is to use SAP solutions to support Celltech around the globe," he said. "We have plans to integrate it with our [research & development] efforts by leveraging mySAP Business Suite software, including mySAP Business Intelligence (mySAP BI) and mySAP Customer Relationship Management (mySAP CRM)."
The implementation will also include the contract and chargeback scenario, which is part of the industry-specific capabilities in the newest version of mySAP CRM.
Dr. Mathias Kirchmer, CEO of IDS Scheer, said that the consultancy's SAP solution implementation tools would help Celltech streamline its processes and unite the company's disparate systems under one platform.
Berwyn, PA — November 10, 2003 — Biotech firm Celltech Group has tapped consultancy IDS Scheer to improve the company's business processes and help deploy the mySAP Business Suite software, including SAP Best Practices for Pharmaceuticals.
Celltech is a leading European biotechnology company, with extensive pharmaceutical operations in the United States and Europe.
IDS said it will provide Celltech with business process consulting services to help maximize the business value of the mySAP Business Suite software implementation. The consultancy is helping Celltech leverage the capabilities of the SAP Best Practices for Pharmaceuticals that will form the backbone of the SAP solution implementation.
The first phase, scheduled to go live in January 2005, will replace Celltech North America's disparate legacy systems with an implementation that will support multiple business processes — including sales, inventory and contract management — on a single platform. Pending the results of phase one, Celltech plans a global rollout across the entire organization.
According to David Mayor, project leader on the Celltech SAP implementation team, the decision to engage IDS Scheer was based on the solutions approach presented. "We found that IDS Scheer consultants took the time to understand our needs and presented a comprehensive solution versus a boxed product," he said.
Richard Simon, IT systems architect who is working with Mayor on managing the technical infrastructure aspects of the SAP solution implementation at Celltech, cited the scalability of the SAP platform as a key plus for the solution. "It was critical for us to buy into an expandable platform to scale with us today and deploy more cost-effectively in the future," Simon said.
Simon wants to optimize the SAP solution landscape with clustering and redundancy for high availability and multi-site presence for disaster recovery so that SAP can become the cornerstone business enabling platform for future initiatives within Celltech. "Our eventual goal is to use SAP solutions to support Celltech around the globe," he said. "We have plans to integrate it with our [research & development] efforts by leveraging mySAP Business Suite software, including mySAP Business Intelligence (mySAP BI) and mySAP Customer Relationship Management (mySAP CRM)."
The implementation will also include the contract and chargeback scenario, which is part of the industry-specific capabilities in the newest version of mySAP CRM.
Dr. Mathias Kirchmer, CEO of IDS Scheer, said that the consultancy's SAP solution implementation tools would help Celltech streamline its processes and unite the company's disparate systems under one platform.
Companies in this article
